822 related articles for article (PubMed ID: 16675892)
1. Deletions of genes encoding calcitonin/alpha-CGRP, amylin and calcitonin receptor have given new and unexpected insights into the function of calcitonin receptors and calcitonin receptor-like receptors in bone.
Lerner UH
J Musculoskelet Neuronal Interact; 2006; 6(1):87-95. PubMed ID: 16675892
[TBL] [Abstract][Full Text] [Related]
2. The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism.
Naot D; Cornish J
Bone; 2008 Nov; 43(5):813-8. PubMed ID: 18687416
[TBL] [Abstract][Full Text] [Related]
3. Functional interaction of G protein-coupled receptors of the adrenomedullin peptide family with accessory receptor-activity-modifying proteins (RAMP).
Born W; Muff R; Fischer JA
Microsc Res Tech; 2002 Apr; 57(1):14-22. PubMed ID: 11921352
[TBL] [Abstract][Full Text] [Related]
4. Receptor autoradiography as mean to explore the possible functional relevance of neuropeptides: focus on new agonists and antagonists to study natriuretic peptides, neuropeptide Y and calcitonin gene-related peptides.
Dumont Y; Chabot JG; Quirion R
Peptides; 2004 Mar; 25(3):365-91. PubMed ID: 15134861
[TBL] [Abstract][Full Text] [Related]
5. Expression of the calcitonin receptor, calcitonin receptor-like receptor, and receptor activity modifying proteins during osteoclast differentiation.
Granholm S; Lundberg P; Lerner UH
J Cell Biochem; 2008 Jun; 104(3):920-33. PubMed ID: 18384073
[TBL] [Abstract][Full Text] [Related]
6. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
[TBL] [Abstract][Full Text] [Related]
7. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor.
McLatchie LM; Fraser NJ; Main MJ; Wise A; Brown J; Thompson N; Solari R; Lee MG; Foord SM
Nature; 1998 May; 393(6683):333-9. PubMed ID: 9620797
[TBL] [Abstract][Full Text] [Related]
8. Adrenomedullin and CGRP interact with endogenous calcitonin-receptor-like receptor in endothelial cells and induce its desensitisation by different mechanisms.
Nikitenko LL; Blucher N; Fox SB; Bicknell R; Smith DM; Rees MC
J Cell Sci; 2006 Mar; 119(Pt 5):910-22. PubMed ID: 16495482
[TBL] [Abstract][Full Text] [Related]
9. Receptor pharmacology.
Young A
Adv Pharmacol; 2005; 52():47-65. PubMed ID: 16492540
[TBL] [Abstract][Full Text] [Related]
10. Comparisons between the effects of calcitonin receptor-stimulating peptide and intermedin and other peptides in the calcitonin family on bone resorption and osteoclastogenesis.
Granholm S; Henning P; Lerner UH
J Cell Biochem; 2011 Nov; 112(11):3300-12. PubMed ID: 21748786
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of amylin in bone.
Tamura T; Miyaura C; Owan I; Suda T
J Cell Physiol; 1992 Oct; 153(1):6-14. PubMed ID: 1325980
[TBL] [Abstract][Full Text] [Related]
12. Investigation of CGRP receptors and peptide pharmacology in human coronary arteries. Characterization with a nonpeptide antagonist.
Hasbak P; Saetrum Opgaard O; Eskesen K; Schifter S; Arendrup H; Longmore J; Edvinsson L
J Pharmacol Exp Ther; 2003 Jan; 304(1):326-33. PubMed ID: 12490608
[TBL] [Abstract][Full Text] [Related]
13. Distinct receptor activity-modifying protein domains differentially modulate interaction with calcitonin receptors.
Udawela M; Christopoulos G; Tilakaratne N; Christopoulos A; Albiston A; Sexton PM
Mol Pharmacol; 2006 Jun; 69(6):1984-9. PubMed ID: 16531504
[TBL] [Abstract][Full Text] [Related]
14. Decreased bone formation and osteopenia in mice lacking alpha-calcitonin gene-related peptide.
Schinke T; Liese S; Priemel M; Haberland M; Schilling AF; Catala-Lehnen P; Blicharski D; Rueger JM; Gagel RF; Emeson RB; Amling M
J Bone Miner Res; 2004 Dec; 19(12):2049-56. PubMed ID: 15537449
[TBL] [Abstract][Full Text] [Related]
15. The effects of C-terminal truncation of receptor activity modifying proteins on the induction of amylin receptor phenotype from human CTb receptors.
Udawela M; Christopoulos G; Morfis M; Tilakaratne N; Christopoulos A; Sexton PM
Regul Pept; 2008 Jan; 145(1-3):65-71. PubMed ID: 17884192
[TBL] [Abstract][Full Text] [Related]
16. Multiple ramp domains are required for generation of amylin receptor phenotype from the calcitonin receptor gene product.
Zumpe ET; Tilakaratne N; Fraser NJ; Christopoulos G; Foord SM; Sexton PM
Biochem Biophys Res Commun; 2000 Jan; 267(1):368-72. PubMed ID: 10623626
[TBL] [Abstract][Full Text] [Related]
17. Role of the N-terminal domain of the calcitonin receptor-like receptor in ligand binding.
Chauhan M; Rajarathnam K; Yallampalli C
Biochemistry; 2005 Jan; 44(2):782-9. PubMed ID: 15641806
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological and kinetic characterization of adrenomedullin 1 and calcitonin gene-related peptide 1 receptor reporter cell lines.
Wunder F; Rebmann A; Geerts A; Kalthof B
Mol Pharmacol; 2008 Apr; 73(4):1235-43. PubMed ID: 18174292
[TBL] [Abstract][Full Text] [Related]
19. Genomic and expression analysis of canine calcitonin receptor-stimulating peptides and calcitonin/calcitonin gene-related peptide.
Osaki T; Katafuchi T; Minamino N
J Biochem; 2008 Oct; 144(4):419-30. PubMed ID: 18558619
[TBL] [Abstract][Full Text] [Related]
20. Calcitonin receptor-stimulating peptide: Its evolutionary and functional relationship with calcitonin/calcitonin gene-related peptide based on gene structure.
Katafuchi T; Yasue H; Osaki T; Minamino N
Peptides; 2009 Sep; 30(9):1753-62. PubMed ID: 19540291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
